Company intelligence / Profile preview

Outlier Biopharma

Cambridge, Massachusetts, United Statesoutlier.org ↗

Ownership: Private
Employees: ~30
Development stage: Commercial

Overview

Outlier Biopharma operates as a vertically integrated biotechnology company specializing in research, development, manufacturing, and distribution of cannabis and cannabinoid-based products. The company provides contract extraction services using both solvent-based and solvent-less methods. It also offers white-label product manufacturing for wholesale clients. No clinical trial results are reported; the business model centers around B2B services rather than proprietary drug development.

Therapeutic areas: Neurology
Modalities: Small moleculeBiologic
Industry: Non-Drug Biotech

Partnerships

Not specifically listed; business model emphasizes partnerships with growers/producers via contract services

Beyond the preview

Go deeper on Outlier Biopharma.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Outlier Biopharma.

Explore the full profile